Skip to main content
Erschienen in: Journal of Clinical Immunology 2/2014

01.02.2014 | Astute Clinician Report

Gastric Adenocarcinoma in the Context of X-linked Agammaglobulinemia

Case Report and Review of the Literature

verfasst von: Aidé Tamara Staines Boone, María Guadalupe Torres Martínez, Gabriela López Herrera, Julia O. de Leija Portilla, Sara Elva Espinosa Padilla, Francisco J. Espinosa Rosales, Saúl Oswaldo Lugo Reyes

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The hallmarks of X-linked Agammaglobulinemia (XLA) are panhypogammaglobulinemia, absent B-cells, and recurrent sinopulmonary and gastrointestinal infections starting at an early age, as well as other infections like cellulitis, meningitis, arthritis and sepsis. A number of non-infectious complications have been reported in these patients, including autoimmune diseases and malignancy, especially lymphomas. Here, we report the case of a 30-year old man who developed gastric adenocarcinoma in the context of XLA. Previous reports of, and hypotheses addressing the development of cancer in patients with XLA, are also summarized. Solid cancer in XLA affects mainly the gastrointestinal tract and seems to be related to chronic infection. A natural evolution can be traced back from gastric adenocarcinoma to megaloblastic anemia due to achlorhydria in the context of chronic infection; periodic endoscopy thus seems justified to detect and treat carcinoma in early stages.
Literatur
1.
Zurück zum Zitat Hussain A, Yu L, Faryal R, Mohammad DK, Mohamed AJ, Smith CI. TEC family kinases in health and disease—loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK. FEBS J. 2011;278(12):2001–10.PubMedCrossRef Hussain A, Yu L, Faryal R, Mohammad DK, Mohamed AJ, Smith CI. TEC family kinases in health and disease—loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK. FEBS J. 2011;278(12):2001–10.PubMedCrossRef
2.
Zurück zum Zitat Van der Hilst JC, Smits BW, van der Meer JW. Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. Neth J Med. 2002;60(3):140–7.PubMed Van der Hilst JC, Smits BW, van der Meer JW. Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. Neth J Med. 2002;60(3):140–7.PubMed
3.
Zurück zum Zitat Kinlen LJ, Webster AD, Bird AG, Haile R, Peto J, Soothill JF, et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet. 1985;1(8423):263–6.PubMedCrossRef Kinlen LJ, Webster AD, Bird AG, Haile R, Peto J, Soothill JF, et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet. 1985;1(8423):263–6.PubMedCrossRef
4.
Zurück zum Zitat Zenone T, Souillet G. [Cancer and primary humoral immunodeficiency]. Bull Cancer. 1997;84(8):813–21. Cancer et deficit primitif de l’immunite humorale. Zenone T, Souillet G. [Cancer and primary humoral immunodeficiency]. Bull Cancer. 1997;84(8):813–21. Cancer et deficit primitif de l’immunite humorale.
5.
Zurück zum Zitat Vajdic CM, Mao L, van Leeuwen MT, Kirkpatrick P, Grulich AE, Riminton S. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood. 2010;116(8):1228–34.PubMedCrossRef Vajdic CM, Mao L, van Leeuwen MT, Kirkpatrick P, Grulich AE, Riminton S. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood. 2010;116(8):1228–34.PubMedCrossRef
6.
Zurück zum Zitat Lederman HM. Cancer in children with primary or secondary immunodeficiencies. J Pediatr. 1995;127(2):335.PubMedCrossRef Lederman HM. Cancer in children with primary or secondary immunodeficiencies. J Pediatr. 1995;127(2):335.PubMedCrossRef
7.
Zurück zum Zitat Bachmeyer C, Monge M, Cazier A, Le Deist F, de Saint Basile G, Durandy A, et al. Gastric adenocarcinoma in a patient with X-linked agammaglobulinaemia. Eur J Gastroenterol Hepatol. 2000;12(9):1033–5.PubMedCrossRef Bachmeyer C, Monge M, Cazier A, Le Deist F, de Saint Basile G, Durandy A, et al. Gastric adenocarcinoma in a patient with X-linked agammaglobulinaemia. Eur J Gastroenterol Hepatol. 2000;12(9):1033–5.PubMedCrossRef
8.
Zurück zum Zitat Lackmann GM, Poremba C, Wahn V, et al. X-gebundene Agammaglobulinämie, chronisch-atrophische Gastritis und Adenokarzinom des Magens bei einem 15-jährigen Jungen. Monatsschr Kinderheilkd. 2007;155(1):S6–9.CrossRef Lackmann GM, Poremba C, Wahn V, et al. X-gebundene Agammaglobulinämie, chronisch-atrophische Gastritis und Adenokarzinom des Magens bei einem 15-jährigen Jungen. Monatsschr Kinderheilkd. 2007;155(1):S6–9.CrossRef
9.
Zurück zum Zitat Lavilla P, Gil A, Rodriguez MC, Dupla ML, Pintado V, Fontan G. X-linked agammaglobulinemia and gastric adenocarcinoma. Cancer. 1993;72(5):1528–31.PubMedCrossRef Lavilla P, Gil A, Rodriguez MC, Dupla ML, Pintado V, Fontan G. X-linked agammaglobulinemia and gastric adenocarcinoma. Cancer. 1993;72(5):1528–31.PubMedCrossRef
10.
Zurück zum Zitat Brosens LA, Tytgat KM, Morsink FH, Sinke RJ, Ten Berge IJ, Giardiello FM, et al. Multiple colorectal neoplasms in X-linked agammaglobulinemia. Clin Gastroenterol Hepatol. 2008;6(1):115–9.PubMedCrossRef Brosens LA, Tytgat KM, Morsink FH, Sinke RJ, Ten Berge IJ, Giardiello FM, et al. Multiple colorectal neoplasms in X-linked agammaglobulinemia. Clin Gastroenterol Hepatol. 2008;6(1):115–9.PubMedCrossRef
11.
Zurück zum Zitat Chisuwa H, Mori T, Fujimori K, Shigeno T, Maejima T. Colorectal cancer in a young adult with X-linked agammaglobulinemia (XLA). Report of a case. Nihon Shokakibyo Gakkai Zasshi. 1999;96(12):1392–5.PubMed Chisuwa H, Mori T, Fujimori K, Shigeno T, Maejima T. Colorectal cancer in a young adult with X-linked agammaglobulinemia (XLA). Report of a case. Nihon Shokakibyo Gakkai Zasshi. 1999;96(12):1392–5.PubMed
12.
Zurück zum Zitat van der Meer JW, Weening RS, Schellekens PT, van Munster IP, Nagengast FM. Colorectal cancer in patients with X-linked agammaglobulinaemia. Lancet. 1993;341(8858):1439–40.PubMedCrossRef van der Meer JW, Weening RS, Schellekens PT, van Munster IP, Nagengast FM. Colorectal cancer in patients with X-linked agammaglobulinaemia. Lancet. 1993;341(8858):1439–40.PubMedCrossRef
13.
Zurück zum Zitat Adachi Y, Mori M, Kido A, Shimono R, Suehiro T, Sugimachi K. Multiple colorectal neoplasms in a young adult with hypogammaglobulinemia. Report of a case. Dis Colon Rectum. 1992;35(2):197–200.PubMedCrossRef Adachi Y, Mori M, Kido A, Shimono R, Suehiro T, Sugimachi K. Multiple colorectal neoplasms in a young adult with hypogammaglobulinemia. Report of a case. Dis Colon Rectum. 1992;35(2):197–200.PubMedCrossRef
14.
Zurück zum Zitat Echave-Sustaeta JM, Villena V, Verdugo M, Lopez-Encuentra A, de Agustin P, Alberti N. X-linked agammaglobulinaemia and squamous lung cancer. Eur Respir J. 2001;17(3):570–2.PubMedCrossRef Echave-Sustaeta JM, Villena V, Verdugo M, Lopez-Encuentra A, de Agustin P, Alberti N. X-linked agammaglobulinaemia and squamous lung cancer. Eur Respir J. 2001;17(3):570–2.PubMedCrossRef
15.
Zurück zum Zitat Sasi OA, Sathiapalan R, Rifai A, Tulbah AM, Al-Mehaidib A, Kofide A, et al. Colonic neuroendocrine carcinoma in a child. Pediatr Radiol. 2005;35(3):339–43.PubMedCrossRef Sasi OA, Sathiapalan R, Rifai A, Tulbah AM, Al-Mehaidib A, Kofide A, et al. Colonic neuroendocrine carcinoma in a child. Pediatr Radiol. 2005;35(3):339–43.PubMedCrossRef
16.
Zurück zum Zitat Wang Y, Kanegane H, Wang X, Han X, Zhang Q, Zhao S, et al. Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China. J Clin Immunol. 2009;29(3):352–6.PubMedCrossRef Wang Y, Kanegane H, Wang X, Han X, Zhang Q, Zhao S, et al. Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China. J Clin Immunol. 2009;29(3):352–6.PubMedCrossRef
17.
Zurück zum Zitat Lackmann GM, Wahn V, Poremba C, et al. A teenager with X-linked agammaglobulinemia and vitamin B12 deficiency anemia. J Pediatr Gastroenterol Nutr. 2005;41:360–2.PubMedCrossRef Lackmann GM, Wahn V, Poremba C, et al. A teenager with X-linked agammaglobulinemia and vitamin B12 deficiency anemia. J Pediatr Gastroenterol Nutr. 2005;41:360–2.PubMedCrossRef
19.
Zurück zum Zitat Aspalter RM, Sewell WA, Dolman K, Farrant J, Webster AD. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol. 2000;121(3):506–14.PubMedCentralPubMedCrossRef Aspalter RM, Sewell WA, Dolman K, Farrant J, Webster AD. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol. 2000;121(3):506–14.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Ritis K, Speletas M, Tsironidou V, Pardali E, Kanariou M, Moschese V, et al. Absence of Bruton’s tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia. Br J Haematol. 1998;102(5):1241–8.PubMedCrossRef Ritis K, Speletas M, Tsironidou V, Pardali E, Kanariou M, Moschese V, et al. Absence of Bruton’s tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia. Br J Haematol. 1998;102(5):1241–8.PubMedCrossRef
21.
Zurück zum Zitat Middendorp S, Zijlstra AJ, Kersseboom R, Dingjan GM, Jumaa H, Hendriks RW. Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity. Blood. 2005;105(1):259–65.PubMedCrossRef Middendorp S, Zijlstra AJ, Kersseboom R, Dingjan GM, Jumaa H, Hendriks RW. Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity. Blood. 2005;105(1):259–65.PubMedCrossRef
22.
Zurück zum Zitat Burger JA, Buggy JJ. Emerging drug profiles: Bruton tyrosine kinase (BTK) inhibitor ibrutinib (PCI-32765). Leuk Lymphoma. 2013. Burger JA, Buggy JJ. Emerging drug profiles: Bruton tyrosine kinase (BTK) inhibitor ibrutinib (PCI-32765). Leuk Lymphoma. 2013.
23.
Zurück zum Zitat Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86(1):31–42.PubMed Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86(1):31–42.PubMed
24.
Zurück zum Zitat Maarschalk-Ellerbroek LJ, Oldenburg B, Mombers IM, Hoepelman AI, Brosens LA, Offerhaus GJ, et al. Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia. Endoscopy. 2013;45(4):320–3.PubMedCrossRef Maarschalk-Ellerbroek LJ, Oldenburg B, Mombers IM, Hoepelman AI, Brosens LA, Offerhaus GJ, et al. Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia. Endoscopy. 2013;45(4):320–3.PubMedCrossRef
25.
Zurück zum Zitat Desar IM, van Deuren M, Sprong T, Jansen JB, Namavar F, Vandenbroucke-Grauls CM, et al. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia. Clin Exp Immunol. 2009;156(3):434–9.PubMedCentralPubMedCrossRef Desar IM, van Deuren M, Sprong T, Jansen JB, Namavar F, Vandenbroucke-Grauls CM, et al. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia. Clin Exp Immunol. 2009;156(3):434–9.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci U S A. 2008;105(11):4358–63.PubMedCentralPubMedCrossRef Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci U S A. 2008;105(11):4358–63.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Slotta JE, Heine S, Kauffels A, Krenn T, Grunhage F, Wagner M, et al. Gastrectomy with isoperistaltic jejunal parallel pouch in a 15-year-old adolescent boy with gastric adenocarcinoma and autosomal recessive agammaglobulinemia. J Pediatr Surg. 2011;46(9):e21–4.PubMedCrossRef Slotta JE, Heine S, Kauffels A, Krenn T, Grunhage F, Wagner M, et al. Gastrectomy with isoperistaltic jejunal parallel pouch in a 15-year-old adolescent boy with gastric adenocarcinoma and autosomal recessive agammaglobulinemia. J Pediatr Surg. 2011;46(9):e21–4.PubMedCrossRef
28.
Zurück zum Zitat O’Connor A, McNamara D, O’Morain CA. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer. Cochrane Database Syst Rev. 2013;9, CD009322.PubMed O’Connor A, McNamara D, O’Morain CA. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer. Cochrane Database Syst Rev. 2013;9, CD009322.PubMed
Metadaten
Titel
Gastric Adenocarcinoma in the Context of X-linked Agammaglobulinemia
Case Report and Review of the Literature
verfasst von
Aidé Tamara Staines Boone
María Guadalupe Torres Martínez
Gabriela López Herrera
Julia O. de Leija Portilla
Sara Elva Espinosa Padilla
Francisco J. Espinosa Rosales
Saúl Oswaldo Lugo Reyes
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 2/2014
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-013-9971-5

Weitere Artikel der Ausgabe 2/2014

Journal of Clinical Immunology 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.